• Colorado’s preschool case is not just about religion. It is about who gets to write the rules for public money.

    ByHarlan Quill

    I was raised on the idea that America is a bargain you can read: the docket is public, the rules are supposed to be legible, and power is supposed to have footnotes.

    So when the Supreme Court takes a case about preschool, I do not hear finger paints. I hear the click of a lock. In 2026, preschool is not just childcare. It is a public benefit and an early test of whether “universal” means what it says on the brochure.

    What the Supreme Court just agreed to hear

    On Monday, April 20, the Supreme Court granted review in St. Mary Catholic Parish v. Roy, a dispute over whether Catholic preschools can participate in Colorado’s state-funded universal preschool program while keeping admissions policies Colorado says violate the program’s nondiscrimination requirements. The Court granted certiorari limited to Questions 1 and 2, meaning the justices are taking a slice of the fight, not the whole cake. And according to reporting on the case, the Court is not using this grant to revisit the 1990 free-exercise precedent Employment Division v. Smith.

    The core dispute, in plain English

    Colorado has a universal pre-K program created by a 2020 ballot measure. The program helps pay for preschool and includes public and private providers, including faith-based ones. But it comes with an equal-opportunity condition: if you take the funding, you cannot turn families away on protected grounds like sexual orientation or gender identity.

    The Catholic plaintiffs say the state is effectively excluding them because their faith-based policies on marriage, sex, and gender shape who they will enroll. Colorado’s answer is essentially: believe what you believe, teach what you teach, but do not take public money to run a publicly subsidized admissions gate that excludes certain families.

    Lower courts sided with Colorado. Now the Supreme Court wants a look.

    The Paine test: who holds the lever?

    In a universal program, the lever is access. If Colorado must fund providers that can exclude some families while taking state money, that is a new kind of publicly backed power: a taxpayer subsidy paired with a private veto over who counts as an acceptable family in the publicly financed system.

    But if the state writes rules that functionally force religious providers to become secular in lived operations, that lever cuts the other way. Government does not need to padlock a church if it can regulate participation in public life until faith becomes a museum piece.

    The liberty ledger and the tradeoff

    • If the preschools win outright: religious providers gain freedom to align admissions with doctrine while receiving public funds. Families headed by same-sex couples, or families with a trans parent, risk being told their taxes support a benefit they cannot use at that provider.
    • If Colorado wins outright: families gain a clearer guarantee that a publicly funded seat is not conditioned on who they are. Religious providers remain free to operate privately, but must forgo a subsidy in a market where the subsidy changes what survival looks like.

    The Orwell check: mind the euphemisms

    Two translation tricks are doing weightlifting here: calling a nondiscrimination condition “anti-Catholic,” and calling a request that may change who the program is for an “accommodation.” The Court’s job is to strip the language down to the studs and decide what is being built.

    One question for the comments: if your tax dollars pay for a universal benefit, what is the fairest rule for who gets to say no at the door?

  • HUD’s ‘Eligibility Verification’ Rule: When Paperwork Becomes a Door-Knock

    ByHarlan Quill

    I spent part of this morning doing the civic version of crawling through a dusty library basement: reading a Federal Register notice like a warranty, hunting for the fine print that bites later. Outside, America argues about borders like it is a cable segment. Inside, policy does what it always does. It turns people into categories, categories into paperwork, and paperwork into a trapdoor.

    What HUD proposed, and why today matters

    In the February 20, 2026 Federal Register, HUD proposed a rule titled Housing and Community Development Act of 1980: Verification of Eligible Status. The public comment deadline is today, April 21, 2026. That is not trivia. That is the last stop before this train either slows down for questions or keeps rolling on momentum and euphemism.

    In plain English, the proposal would:

    • Require verification of U.S. citizenship or eligible immigration status for all applicants and recipients in covered HUD programs, regardless of age.
    • Push toward making prorated assistance a temporary condition while verification is pending, rather than something that can continue indefinitely under current practice.

    The practical pressure point is obvious: mixed-status families, where eligible members can receive assistance and ineligible members are not counted for subsidy purposes. It is still a proposed rule, not a final one. In Washington, that is the government clearing its throat before it starts moving furniture.

    The Orwell check: “verification” as a softer word for destabilization

    “Verification of Eligible Status” sounds like a librarian stamping a card. It is not. It ties continued shelter to producing the right documents, on demand, on time, through the correct channel, with little patience for the mess of real life.

    AP reported in February that advocates fear the proposal could push tens of thousands out and effectively bar mixed-status families from HUD housing. The administration frames it as closing a “loophole” and stopping “fraudsters gaming the system.” That is a familiar executive-power move: define a problem so broadly that collateral damage can be filed under “enforcement.”

    The liberty ledger: who gets stability, who gets the knock

    Gains: a cleaner spreadsheet and a talking point about uniform enforcement and fewer gray areas. Bureaucracies love clean categories. Politics loves a villain.

    Losses: families lose the ability to stay together without risking the roof. Even if you like strict eligibility lines, the mechanism should make you flinch: housing assistance becomes leverage at the most fragile seam in a household.

    And it does not stop at immigrants. AP flagged a documentation land mine: if the system demands proof people do not readily have, the system is not verifying eligibility so much as testing who can survive bureaucracy. AP also reported that millions of U.S. citizens lack easy access to documentation proving citizenship.

    The Paine test and the tradeoff: where are the guardrails?

    The Paine test: this concentrates power by turning rent calculation into a compliance checkpoint and housing agencies into an enforcement arm, all via administrative rulemaking, the midnight committee room where big changes arrive labeled “technical.”

    The tradeoff: if the goal is integrity, the price is destabilizing eligible people, including citizen kids in mixed-status households. If HUD proceeds, the bare minimum is clear due process before termination, meaningful cure periods for documentation problems, explicit protections for children and caregivers, and transparent evidence for any broad “fraud” claims with independent oversight. And if HUD says it will not cause homelessness, it should be willing to publish impact tracking: how many households lose assistance, where they go, and what it costs cities and states.

    Tonight is the deadline. Comment if you can. Call your members of Congress and ask what oversight they plan to demand. Watch what happens in court, because rules like this often end up there. One last question for the town hall: if a policy’s selling point is that it scares people out of their homes, are we solving a problem, or just relocating it into the street where everyone can see it?

  • GPS III SV10 and the Tyranny of the Time-Salesmen

    ByBrick Tungsten

    Smoke from the grill is thick tonight, and it sounds like an F-150 idling while the Space Force gears up for another GPS mission. That quiet countdown? It is a freedom sermon. When the stars are timed right, the country can move with confidence. When they are not, you get chaos, delays, and a schedule that someone in an office decided without ever touching the controls.

    nn

    Launch setup: GPS III SV10 goes up at 2:53 a.m. EDT

    n

    Space.com reports that SpaceX is set to launch GPS III SV10 for the U.S. Space Force at 2:53 a.m. EDT during a 15-minute launch window from Cape Canaveral Space Force Station. The payload is described as the 10th and final satellite in the advanced GPS III line.

    nn

    Accuracy and jam resistance upgrades

    n

    Space Force messaging highlighted that GPS III satellites bring a three-fold increase in positional accuracy and an eight-fold improvement in jam resistance compared to prior versions.

    nn

    The switch behind SV10

    n

    Space.com says SV10 was originally planned to fly on ULA’s Vulcan Centaur, but it was switched to a Falcon 9 after issues the Space Force described with Vulcan’s solid rocket boosters. And when timetables get shaken, incentives show up fast. The paperwork grows, the milestones stretch, and somebody in the real world waits.

    nn

    What happens after liftoff

    n

    Spaceflight Now adds that SV10 is encapsulated in two halves of the payload fairing, with one half new and the other reused from an earlier GPS III mission. After deployment, the satellite will raise its orbit over 10 days to reach its operational position, followed by 2 to 3 days of on-orbit testing before operations transition to the Space Force.

    nn

    Laser communications demo in the mix

    n

    Spaceflight Now also notes an optical cross-link demo, a laser communications system being tested on this mission before it gets integrated on the next-generation GPS IIIF satellites.

    nn

    Timing is the whole point

    n

    GPS III SV10 is the finale of the advanced GPS III line, and the mission is being executed with a launch window that matters because timing matters. When coordination works, everybody who depends on GPS gets precision. When teams bicker and stall, the rest of the country pays.

    nn

    Competition without the drama

    n

    SpaceX is getting the mission in this moment because it can execute, and because the Space Force is willing to move. Real flexibility looks like swapping launch arrangements to keep the schedule alive and the hardware headed toward its operational position.

  • Google’s Monopoly Trial Was Supposed to Break the Machine. Instead, the Machine Asked for a ‘Technical Committee.’

    ByJustin Jest

    I am back under that courthouse air that tastes like copier toner and quiet threats. The hallway is all suits, soft shoes, and louder whispers. Outside, sirens do their municipal hymn. Inside, the country is trying to decide whether the company sitting on the front door of the internet has to stop acting like it owns the building.

    Remedies hearing begins in the U.S. search monopoly case against Google

    Today, April 21, 2026, the remedies phase in the government’s search monopoly case against Google is set to begin in federal court, with the schedule running into May. This is the part where we stop debating what happened and start fighting about what has to change.

    And right on time, the polite policy answer floating through the marble hallways is not “break it up,” or “stop paying for defaults,” or “open the pipes.” It is the bureaucratic comfort blanket: committees, compliance plans, dashboards, and oversight structures so dense you need a second monopoly just to translate them.

    Translation: if you cannot beat a monopolist cleanly, you drown everyone else in process and call it reform.

    Translation: A “remedy” can be a cure, or it can be a delay tactic with better stationery

    Here is what we actually know. The Justice Department has been pursuing remedies after a court found Google illegally monopolized key search markets. DOJ’s own public framing is that meaningful remedies are needed to restore competition because Google used anticompetitive tactics to keep its grip on search and search advertising for years.

    Now we are in the phase where the court decides which levers get pulled. This is where Big Tech runs its favorite trick: take a structural problem and rebrand it as an engineering project.

    When you hear “technical committee” in an antitrust remedy, hear the quieter sentence underneath: let the defendant help design the handcuffs. Not because anyone is naive. Because the monopoly has been allowed to function like a regulated utility in everything but name, and the rules were never written.

    A Knight-Georgetown Institute report circulating this month makes the committee idea sound tidy: metrics, monitoring, “ground truth,” accountability. It reads like a spreadsheet that wants to be a constitution. But the U.S. does not have a metrics problem. It has a power problem.

    Here is the mechanism: Monopoly power hides inside defaults, contracts, and distribution

    Google’s moat has never been only about being “better.” It is about being placed. Default placement. Distribution. The frictionless habit loop. The search box is not just software. It is infrastructure. Big firms buy their way into default position like they are purchasing gravity.

    So remedies that only tweak behavior can fail on contact with reality. A “don’t do that again” order does not automatically unwind distribution advantages. A committee does not change the fact that a gatekeeper can tilt the ramp while calling it “optimizing the user experience.”

    And the calendar is the monopolist’s best friend. Every month of remedies litigation is another month of data advantage, advertiser lock-in, and bundling that makes alternatives feel like a downgrade, not because they are worse, but because they are starved of scale.

    While the courtroom argues, the product surface shifts. Search becomes “AI answers.” Ads become “AI recommendations.” The monopoly does not die. It molt-shifts into a new interface and shrugs: you cannot regulate what you cannot define.

    Follow the money: Who pays for “oversight” and who profits from “compliance”

    If the remedy becomes a complex compliance regime, Google benefits first. Complexity is a defensive wall. A sprawling remedy creates endless interpretation space, and interpretation space is where enforcement slows and delay lives comfortably.

    Then the compliance economy eats: boutique firms, monitoring vendors, former regulators turned “independent experts.” They will sell “governance.” They will monetize the gap between what the law demands and what the political system is willing to enforce.

    Competitors can be strung along with promises of access “later,” through a controlled process, under criteria written in language that sounds neutral but behaves like a velvet rope.

    And the public pays twice. We pay once through monopoly rent moving through advertising into everything. We pay again when the remedy becomes a permanent bureaucracy that never quite fixes the underlying extraction machine.

    The quiet part: the politically comfortable outcome is not a broken monopoly. It is a managed monopoly with nicer manners.

    The quiet part: Big Tech wants antitrust to become “risk management,” not power redistribution

    Structural remedies change incentives. Behavioral remedies can be negotiated, interpreted, appealed, “complied with,” and then outpaced by redesign. A technical committee can become a permanent fog machine: reports, meetings, “progress,” and not much new choice in your browser.

    To be clear, technical oversight is not inherently bad. But if oversight is the headline and power is the footnote, the remedy is already lost. The stakes are not abstract. Search sits downstream of jobs, housing, health information, political persuasion, local news survival, and prices. When one firm sets the rules of discoverability, it does not just organize knowledge. It organizes power.

    Mic drop: if the United States can prove monopoly power in court but cannot impose remedies that rewire incentives, antitrust becomes theater and monopoly becomes permanent. This is the moment for hard oversight, public reporting with teeth, court-enforced deadlines, and watchdogs who do not take future consulting gigs, plus pressure from workers, advertisers, publishers, and voters tired of being treated like captive “users” in someone else’s revenue model.

  • Kalshi vs. New Jersey: Supreme Court Showdown for the Sports Betting Label

    ByBrick Tungsten

    The air is thick with grilled smoke and the kind of TV noise you hear when grown men argue about sports like it is a second Founding Fathers document. Tonight, I smell a different kind of heat: prediction markets, federal court, and state regulators circling like vultures over a brisket tray.

    April 6, 2026: Third Circuit throws the flag

    On April 6, 2026, the U.S. Court of Appeals for the Third Circuit ruled in KalshiEX LLC v. New Jersey that the Commodity Exchange Act preempts New Jersey from enforcing its gambling laws against Kalshi’s sports-related event contracts, while Kalshi trades them on a federally licensed designated contract market under CFTC oversight.

    The court affirmed a preliminary injunction. Translation: New Jersey got put on pause at the door. Before that pause, the state sent Kalshi a cease-and-desist letter aimed at its sports event contracts and warned it could seek measures under state law if Kalshi did not stop.

    Why are regulators sweating like it is July Fourth?

    Because incentives never take a day off. Fortune reported that sports wagers make up more than 85% of Kalshi activity. It also said Kalshi brought in about $25 million in fees tied to March Madness during a four-day stretch, and that sector-wide weekly trading volume climbed past $1 billion. Sportsbookreview echoed the same core points, adding that Kalshi’s trading is dominated by sports contracts and that states have moved hard, including an Ohio penalty and cease-and-desist actions from Arizona, Connecticut, and Illinois.

    Court logic: federal license means federal rules

    Now to the court’s logic. The Third Circuit framed the issue around preemption and CFTC exclusive jurisdiction for swaps traded on CFTC-licensed designated contract markets. The contracts at stake were described as event contracts, a type of derivative within the Commodity Exchange Act structure. One judge dissented, raising concerns about whether the majority was effectively changing the label game. The majority did not buy the rebrand panic, and it let the injunction stand.

    So what’s next for America?

    Fortune says the dispute could be headed to the Supreme Court, especially if more appeals deepen the split. Under the grease, it is about power: how much authority states have to police gambling labels when the product fits a federal market category. If Congress wants one nationwide rulebook, legislate it. If states disagree, litigate within the Constitution. And if the Supreme Court has to referee, then let it do its job like a real referee, not a carnival barker.

    Alright, sports fans and policy folks, do you want the Constitution acting like the referee, or do you want regulators calling their own playbook at full volume?

  • Santa Clara’s Super Bowl ‘Reimbursement’ Deal: The Billionaire-Carwash Model of Public Safety

    ByJustin Jest

    I’m hunched over a chipped desk under fluorescent newsroom light, scanner static in one ear and the printer spitting out the real highlight reel: terms, indemnities, reimbursements. Not touchdowns. Paperwork. The language of power when it wants you to confuse a bill with a gift.

    Santa Clara approved a Super Bowl services deal built on reimbursement promises and a backstop

    Here’s the verified core. Santa Clara’s Stadium Authority Board, which is the City Council wearing its other hat, voted 5-2 to approve a Super Bowl LX agreement for Levi’s Stadium. The Bay Area Host Committee is slated to reimburse roughly $6.4 million for costs like law enforcement and safety equipment, plus additional reimbursements tied to venue rent and ticket-related programs. The terms describe up-front payments before the game and the remainder after.

    If the host committee cannot pay, the 49ers’ stadium company is positioned as a financial backstop, with interest if payment lags. That is not civic pride. That is a loan-document vibe dressed up in confetti.

    Santa Clara’s own paperwork for the final League Event Agreement also spells out the city’s role: provide public safety, transportation management, emergency medical response, and related services, guided by a master plan and public safety plan the city controls. It also makes explicit what mega-events always do. The scope of “services” can expand, from the stadium outward, depending on what the NFL machine requests and what the host committee calls necessary.

    The pushback was real. The mayor and vice mayor voted no, citing concerns about getting fully reimbursed and pushing for stronger guarantees. That is not cynicism. That is basic accounting.

    Translation: “reimbursable” means you pay first and argue later

    Translation: reimbursement means the city fronts the staffing, fronts the overtime, fronts the equipment and planning burden, then submits receipts for approval. Even when the language looks protective, the timeline is the tell. The cops, barricades, radios, EMS staging, traffic control, training, and planning meetings all happen on the front end.

    Then comes the documentation phase, the qualified-expenses phase, the “we need more detail” phase. If you have ever watched payment get delayed while someone discovers missing paperwork at the exact moment money is due, you already know the plot.

    Follow the money: the NFL sells prestige, cities sell overtime

    Follow the money: broadcast and advertising money flows to the league and its partners. Team valuation pops for owners. Sponsors get their brand halo. Meanwhile the municipal ledger gets payroll spikes, equipment costs, interagency coordination, and the quiet administrative churn of ensuring nothing goes wrong under a global spotlight.

    And that backstop? A “financial backstop” from the 49ers’ stadium company is a private promise to cover a nonprofit’s obligation if that nonprofit cannot pay. A chain of promises is not the same thing as cash sitting in escrow. Layer the entities and accountability has to file a change-of-address form.

    Here is the mechanism: privatize profit, municipalize risk, call it partnership

    Here is the mechanism: only government can close streets, coordinate emergency management, and deploy police powers at scale. The league cannot do that. It rents that capacity from the public, then calls it civic pride.

    The quiet part is that “no risk to taxpayers” is a slogan, not a guarantee. Risk is whether checks clear, yes. It is also staff time diverted, equipment wear, overtime burnout, and precedent: your public safety workforce scheduled like a private event staffing firm.

    Mic-drop, with receipts: treat these deals like high-risk public contracts. Put reimbursement requests, approvals, denials, and delays on the public record in real time. Demand independent audits. Drag agreements into open hearings where residents and labor can testify. If the numbers do not pencil out, organize and vote like your budget depends on it, because it does.

  • NIH and the Foreign-Ties Gate

    ByBrick Tungsten

    The air over D.C. still smells like burnt charcoal and wet paperwork, and today the NIH is basically turning the SBIR and STTR pipeline into a security checkpoint. Not because science is bad. Because oversight matters, and foreign strings are not a side quest.

    NIH issues a Notice of Information on SBIR and STTR foreign disclosure and risk management

    Served hot off the grill: NIH published a new Notice of Information, NOT-OD-26-074. It lays out policy changes for HHS small-business grant applicants to disclose foreign affiliations, plus how the agency will run due diligence to assess security risks. It also spells out consequences if the foreign-risk picture comes up ugly, including denial of awards and repayment requirements where someone misstates ties or where ownership shifts under the hood.

    Follow the money: transparency for taxpayers, workers, and real innovators

    Who benefits when the government demands visibility? Taxpayers. Workers. And the actual innovators who build on home turf and earn their spot in the American supply chain.

    Under the notice, disclosed foreign affiliations and relationships feed into a due diligence program that can assess things like cybersecurity practices, patent analysis, employee analysis, and even foreign ownership and financial ties. That is not vibes. That is risk management with a checklist aimed at stopping the kind of grift where federal cash shows up, foreign entanglements get hidden, and the intellectual property starts doing laps overseas like it paid tolls.

    The villain is the incentive: control, influence, and technology transfer

    The incentive at the center of the story is power and control. Foreign ties can mean foreign influence, technology transfer, and the slow-motion theft of American ideas. The notice also points to situations where HHS cannot make an award if certain risk categories apply, including connections to a foreign country of concern or listed security-risk entities.

    Security screening without a do-over, plus post-award monitoring

    Sure, mistakes happen. But the notice says applicants and recipients are encouraged to consider security risks, and per the Act, HHS will not give an opportunity to address identified security risks prior to award. Decision gate happens before the check clears.

    After awards, the notice describes post-award monitoring and reporting requirements. If there is a material misstatement posing a national security risk, or a change in ownership or entity structure that meets risk criteria, it describes repayment of amounts received.

    What this means for America: science that stays American

    The notice ties these changes to the reauthorization of SBIR and STTR through September 30, 2031, referencing the Small Business Innovation and Economic Security Act. The goal is straightforward: update the rules based on what the nation learned, and publish the implementation details so applicants know the road rules before they rev.

    So if you are doing honest work, transparency is not your enemy. It is your shield. Now tell me, friends: why would an honest scientist or small-business innovator be scared of disclosing foreign ties instead of trying to dodge the gate?

  • A Syringe Adapter That Unwinds, and a Safety System That Shrugs

    ByHarlan Quill

    I can picture the room because American medicine repeats it daily: fluorescent calm, a chart that reads like a court docket, and a clinician trying to keep a line steady while the system asks them to multitask with “small” surprises.

    This surprise is mechanical. A syringe rotating adapter that is supposed to stay tightened can unwind during use. It’s not flirting with anyone’s freedom. It’s flirting with the patient’s bloodstream.

    FDA posts nationwide recall of Aligned Medical angio packs

    On April 20, 2026, the FDA published a company announcement from Windstone Medical Packaging (doing business as Aligned Medical Solutions) about a nationwide recall of two angiography convenience kits: AMS6908E and AMS6908F, sold as Aligned Medical Angio Pack.

    • Problem: the syringe rotating adapter can unwind, creating a loose connection or full disconnection between syringes and a manifold.
    • Risks described: biohazard exposure for staff, blood loss and infection risk for patients, and potential air in the line, including a possible air embolism.
    • Timeline in the notice: Aligned initiated the recall on April 2, 2026; the company announcement is dated April 16, 2026.
    • Scope: distributed nationwide; kits manufactured October 18, 2024 through November 13, 2025; distributed October 28, 2024 through November 28, 2025.
    • Reported outcomes: Aligned says no injuries have been reported to it to date; the same FDA-posted announcement also states three instances were reported to Medline of inadvertent air injection into a patient and one instance of biohazard exposure, with no deaths reported.

    One sentence in the FDA posting is worth underlining: the agency says it’s sharing the company’s announcement “as a public service” and does not endorse the company or product. Not a scandal. Just the operating model, printed in plain sight.

    Why this is bigger than one kit

    Angiography is not a casual errand. When a connection can loosen mid-procedure, that’s not an inconvenience. That’s a design and quality problem with consequences that move faster than memos.

    It also lives inside kit-ification: kits can standardize and speed work, but they can also spread a single component failure across many packs, facilities, and procedures.

    Earlier this month, MedTech Dive reported that Medline removed certain Namic angiographic rotating adaptor control syringes from the market after complaints of disconnections, and that the FDA posted a warning letter tied to the issue. Different notice, overlapping failure mode, similar risks, including air embolism.

    The Orwell check

    “Convenience kit.” “Rotating adapter.” “Field corrective action.” Calm words for an event that can introduce air into a patient’s line. Precision matters, but so does honesty: if the language is gentler than the risk, we’re laundering anxiety through vocabulary.

    The liberty ledger, the Paine test, and the tradeoff

    The liberty ledger: hospitals get purchasing efficiency; manufacturers and distributors get scale and predictable logistics; clinicians get speed and standardization in theory. Patients only benefit if quality control is relentless and warnings are fast, loud, and actionable. Without guardrails, the patient becomes the shock absorber for the system’s efficiency.

    The Paine test:</strong does this expand liberty or concentrate power? Here, it concentrates operational power over what information moves fast, what moves slow, and who has to guess in the meantime.

    The tradeoff:</strong we buy streamlined procurement and lean workflows. We pay with complexity hidden inside packaging and a recall ecosystem that can arrive after the fact.

    • Recall communication should behave like an emergency alert in the places that actually use the products, not a webpage you have to remember to check.
    • Traceability should work at the kit level so facilities are not forced to play inventory detective on a bad day.
    • Safety should be treated as public trust, with clearer standards for timeliness when severe risks are on the table.

    My last question is the only one that matters: if a device failure can plausibly put air in a patient’s line, why do we still accept a system where the loudest alarm is often a web posting?

  • The Pentagon Wants an Algorithm to Do a Human Job: Vetting Science Without the Humans

    ByJustin Jest

    The courthouse air is stale even when you are nowhere near a courthouse. That is the vibe of American governance in 2026: fluorescent lights, printer paper, and a machine that keeps failing upward. The Pentagon just said it cannot properly vet the ocean of military-funded university research for foreign influence risks because it does not have enough people, so it is going to use computers, including AI, to screen academics instead.

    That is not oversight. That is automation-as-alibi.

    Pentagon turns to AI to screen military-funded academics for China ties after watchdog flags tiny oversight staff

    On April 20, 2026, Defense News reported that after a federal watchdog found a staff of two overseers was insufficient to vet roughly 27,000 academic research awards for ties to adversaries, the Pentagon is moving toward computer screening of military-funded academics, including AI. The report described a recently declassified inspector general report from May 2025 that said disclosures were going unchecked and the department had not requested additional full-time staff to do the review and oversight at scale.

    Two people. Twenty-seven thousand awards.

    So the Pentagon reaches for the shiny object. AI will do the vetting. Or it will do enough of the appearance of vetting to keep the conveyor belt moving.

    And the blast-radius crowd is already warning what this produces: false assumptions, profiling, and a replay of the post-9/11 paranoia cycle, where “national security” becomes a vibes-based prosecution tool. The same reporting points to prior AI-assisted mistakes in congressional reporting that misattributed sponsorship and funding based on sloppy pattern matching.

    Translation: This is not smarter security. This is cheaper blame

    Translation: “Automated vetting and continuous monitoring” means your name, co-authors, affiliations, and citations get fed into a risk-scoring blender and called due diligence.

    Translation: “Augment human expertise” means keep headcount low, keep vendor invoices high, and when somebody innocent gets flagged, let the algorithm take the fall.

    This is the oldest bureaucracy move: starve a function, declare it broken, then replace it with a system that is easier to control, harder to appeal, and conveniently opaque.

    Here is the mechanism: Understaffing creates a vacuum, and AI fills it with fog

    Here is the mechanism: a watchdog says the oversight shop is too small. The correct fix is staffing, training, clear standards, and transparent processes with appeals. The politically convenient fix is software.

    Software offers volume (screen lots of people fast, even if badly), deniability (“the model indicated risk”), and controllability (humans dissent; models get tuned and wrapped in secrecy). Pair that with talk of common grant databases and “continuous monitoring,” and you can see the paperwork future: research governance drifting into surveillance governance.

    Follow the money: Vendors win, researchers and the public pay

    Follow the money: “Advanced analytical tools” are a procurement category and a contractor ecosystem. The incentive is not to hire humans, because humans come with whistleblower protections and the inconvenient habit of writing memos that become evidence.

    False positives get socialized. Researchers lose time and reputation. Students lose stability. Institutions pour money into compliance instead of labs. The public loses research output it already paid for. And when the system inevitably embarrasses itself, the hearing cycle will spin up and the answer will be more tools, more funding, more secrecy. A scandal is not a failure. It is a sales funnel.

    The quiet part: “China” is the justification, but control is the product. If two overseers cannot vet 27,000 awards, hire the staff. Publish clear standards. Create real appeals. Audit the tools before and after deployment. Let inspectors general and watchdogs see the data. Protect whistleblowers. Put it under congressional oversight that is not captured by defense contractors and paranoia entrepreneurs.

    So which is it: are we funding science, or building a surveillance compliance maze that only contractors can navigate?

  • Fast Track, Fine Print: Psychedelics, Ibogaine, and the FDA Clock

    ByHarlan Quill

    I still trust boring rooms: libraries, town halls, courthouse corridors that smell like paper and consequences. In those places, decisions are meant to move at the speed of evidence, not the speed of applause.

    What happened

    On April 18, President Donald Trump signed an executive order directing federal agencies to accelerate the government’s posture toward psychedelic drugs, including ibogaine, which remains a Schedule I controlled drug under federal law. The order points the Food and Drug Administration toward faster review mechanisms for certain psychedelics and directs agencies to build a pathway for patient access under the federal Right to Try framework. It also pushes for quicker rescheduling review after successful Phase 3 trials and promotes federal-state collaboration.

    AP reported the FDA plans to issue national priority vouchers for three psychedelics as soon as next week, a first for psychedelics under that kind of fast-track approach. As described, the public has not been given a clear list of which three substances will receive those vouchers.

    The money and the machinery

    The order tells HHS to allocate at least $50 million, through ARPA-H, to partner with states that have enacted or are building programs to advance psychedelic drugs for serious mental illness. It also directs HHS, the FDA, and the VA to collaborate on clinical trial participation and data sharing, while nodding at privacy constraints such as HIPAA and the Privacy Act. The order includes a standard clause stating it creates no enforceable rights for anyone.

    The staging was not subtle. AP described conservative podcaster Joe Rogan attending the signing, along with veterans, including Marcus Luttrell.

    The tradeoff: speed is not the same thing as freedom

    If a therapy can safely help people with PTSD, depression, or addiction, the system should not move like a filing cabinet with arthritis. But ibogaine is not a harmless wellness fad. AP noted long-standing researcher concerns about cardiotoxicity, reported that ibogaine can cause irregular heart rhythms, and said it has been linked to more than 30 deaths in the medical literature, according to the Multidisciplinary Association for Psychedelic Studies. AP also reported the NIH briefly funded research in the 1990s and discontinued that work due to cardiovascular toxicity concerns.

    Liberty ledger: who gains, who carries the risk, who pays

    • Gains: Patients, including veterans, who feel failed by traditional care; researchers seeking fewer barriers to study Schedule I substances.
    • Risks: Patients mistaking political enthusiasm for a medical guarantee; families left with consent forms after harm; public trust in the FDA’s independence.
    • Money: AP reported an ibogaine clinic operator said treatment can cost roughly $15,000 to $20,000 per person.

    AP also described Texas as a model, citing a state law providing $50 million for ibogaine research and political support from former Gov. Rick Perry. AP described a small Stanford study of 30 veterans treated in Mexico without a placebo group, with an ibogaine regimen paired with magnesium aimed at reducing heart risk. Early signals can justify more research. They cannot substitute for rigorous trials.

    Guardrails before the sprint becomes a pileup

    • Transparency: If priority vouchers are coming, publish criteria, scientific basis, and conflict-of-interest safeguards.
    • Trial rigor: Randomized, controlled trials with careful cardiac screening and monitoring.
    • Privacy and consent: Clear limits on VA-related data sharing and real opt-out paths.
    • Oversight: Congressional briefings, inspector general audits, courts for fraud or negligence, and an FDA that keeps its spine.

    The Paine test is simple: does this expand liberty or concentrate power? Faster treatment access can be pro-liberty. But if speed comes from political pressure, the bill gets paid in trust and safety.

End of content

End of content